<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Li X</submitter><funding>the Major Program of National Natural Science Foundation of China</funding><funding>Guangdong Province Fund for Distinguished Young Scholars</funding><funding>National Key R&amp;amp;D Program of China</funding><funding>the General Program of National Natural Science Foundation of China</funding><funding>Natural Science Foundation of Guangdong Province</funding><funding>National Natural Science Foundation of China</funding><funding>Guangdong Provincial Key Laboratory of Synthetic Genomics</funding><pagination>87-100</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9510856</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>20(1)</volume><pubmed_abstract>Proximity labeling catalyzed by promiscuous enzymes, such as APEX2, has emerged as a powerful approach to characterize multiprotein complexes and protein-protein interactions. However, current methods depend on the expression of exogenous fusion proteins and cannot be applied to identify proteins surrounding post-translationally modified proteins. To address this limitation, we developed a new method to label proximal proteins of interest by antibody-mediated protein A-ascorbate peroxidase 2 (pA-APEX2) labeling (AMAPEX). In this method, a modified protein is bound in situ by a specific antibody, which then tethers a pA-APEX2 fusion protein. Activation of APEX2 labels the nearby proteins with biotin; the biotinylated proteins are then purified using streptavidin beads and identified by mass</pubmed_abstract><journal>Genomics, proteomics &amp; bioinformatics</journal><pubmed_title>Defining Proximity Proteome of Histone Modifications by Antibody-mediated Protein A-APEX2 Labeling.</pubmed_title><pmcid>PMC9510856</pmcid><funding_grant_id>31971354</funding_grant_id><funding_grant_id>32070610</funding_grant_id><funding_grant_id>2021B1515020109</funding_grant_id><funding_grant_id>32090031</funding_grant_id><funding_grant_id>2019YFA0903803</funding_grant_id><funding_grant_id>32000580</funding_grant_id><funding_grant_id>2020B1515120034</funding_grant_id><funding_grant_id>2019B030301006</funding_grant_id><pubmed_authors>Bouchonville KJ</pubmed_authors><pubmed_authors>Chan K</pubmed_authors><pubmed_authors>Zhao W</pubmed_authors><pubmed_authors>Wen Q</pubmed_authors><pubmed_authors>Gan H</pubmed_authors><pubmed_authors>Li N</pubmed_authors><pubmed_authors>Peng H</pubmed_authors><pubmed_authors>Li X</pubmed_authors><pubmed_authors>Offer SM</pubmed_authors><pubmed_authors>Gao Y</pubmed_authors><pubmed_authors>Wang W</pubmed_authors><pubmed_authors>Wang Z</pubmed_authors><pubmed_authors>Zhou J</pubmed_authors></additional><is_claimable>false</is_claimable><name>Defining Proximity Proteome of Histone Modifications by Antibody-mediated Protein A-APEX2 Labeling.</name><description>Proximity labeling catalyzed by promiscuous enzymes, such as APEX2, has emerged as a powerful approach to characterize multiprotein complexes and protein-protein interactions. However, current methods depend on the expression of exogenous fusion proteins and cannot be applied to identify proteins surrounding post-translationally modified proteins. To address this limitation, we developed a new method to label proximal proteins of interest by antibody-mediated protein A-ascorbate peroxidase 2 (pA-APEX2) labeling (AMAPEX). In this method, a modified protein is bound in situ by a specific antibody, which then tethers a pA-APEX2 fusion protein. Activation of APEX2 labels the nearby proteins with biotin; the biotinylated proteins are then purified using streptavidin beads and identified by mass</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Feb</publication><modification>2026-05-27T22:53:37.873Z</modification><creation>2025-04-06T12:12:58.717Z</creation></dates><accession>S-EPMC9510856</accession><cross_references><pubmed>34555496</pubmed><doi>10.1016/j.gpb.2021.09.003</doi></cross_references></HashMap>